Rotavirus vaccine efficacy: current status and areas for improvement

References

• Guerrant RL, Oriá RB, Moore SR, Oriá MOB, Lima AAM. Malnutrition as an enteric infectious disease with long-term effects on child development. Nutr Rev. 2008;66:487–505. http://nutritionreviews.oxfordjournals.org/content/66/9/487.abstract.
   PubMed Web of Science ®Google Scholar
• Korpe PS, Petri WA Jr. Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol Med. 2012;18:328–336. doi:https://doi.org/10.1016/j.molmed.2012.04.007.
   PubMed Web of Science ®Google Scholar
• Crane RJ, Jones KDJ, Berkley JA. Environmental enteric dysfunction: an overview. Food Nutr Bull. 2015;36:S76–87. http://fnb.sagepub.com/content/36/1_suppl1/S76.abstract.
   PubMed Web of Science ®Google Scholar
• Lindenbaum J, Gerson C, Kent T. Recovery of small-intestinal structure and function after residence in the tropics: I. Studies in peace corps volunteers. Ann Intern Med. 1971;74:218–222. doi:https://doi.org/10.7326/0003-4819-74-2-218.
   PubMed Web of Science ®Google Scholar
• Naylor C, Lu M, Haque R, Mondal D, Buonomo E, Nayak U, Mychaleckyj JC, Kirkpatrick B, Colgate R, Carmolli M, et al. Environmental enteropathy, oral vaccine failure and growth faltering in infants in Bangladesh. EBioMedicine. 2015;2:1759–1766. doi:https://doi.org/10.1016/j.ebiom.2015.09.036.
   PubMed Web of Science ®Google Scholar
• Taniuchi M, Platts-Mills JA, Begum S, Uddin MJ, Sobuz SU, Liu J, Kirkpatrick BD, Colgate ER, Carmolli MP, Dickson DM, et al. Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants. Vaccine. 2016;34:3068–3075. http://www.sciencedirect.com/science/article/pii/S0264410X16302547.
   PubMed Web of Science ®Google Scholar
• Praharaj I, John SM, Bandyopadhyay R, Kang G. Probiotics, antibiotics and the immune responses to vaccines. Philos Trans R Soc B Biol Sci. 2015;370:20140144. http://rstb.royalsocietypublishing.org/content/370/1671/20140144.abstract.
   PubMed Web of Science ®Google Scholar
• Huda MN, Lewis Z, Kalanetra KM, Rashid M, Ahmad SM, Raqib R, Qadri F, Underwood MA, Mills DA, Stephensen CB. Stool microbiota and vaccine responses of infants. Pediatrics. 2014;134:e362 LP–e372. http://pediatrics.aappublications.org/content/134/2/e362.abstract.
   Web of Science ®Google Scholar
• Lazarus RP, John J, Shanmugasundaram E, Rajan AK, Thiagarajan S, Giri S, Babji S, Sarkar R, Kaliappan PS, Venugopal S, et al. The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: A randomized, factorial design, placebo-controlled study among Indian infants. Vaccine. 2018;36:273–279. http://www.sciencedirect.com/science/article/pii/S0264410X1731071X.
   PubMed Web of Science ®Google Scholar
• Parker EPK, Praharaj I, Zekavati A, Lazarus RP, Giri S, Operario DJ, Liu J, Houpt E, Iturriza-Gómara M, Kampmann B, et al. Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India. Vaccine. 2018;36:264–272. http://www.sciencedirect.com/science/article/pii/S0264410X17315955.
   PubMed Web of Science ®Google Scholar
• Troeger C, Forouzanfar M, Rao PC, Khalil I, Brown A, Reiner RC Jr, Fullman N, Thompson RL, Abajobir A, Ahmed M, et al. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017;17:909–948. doi:https://doi.org/10.1016/S1473-3099(17)30276-1.
   PubMed Web of Science ®Google Scholar
• Bishop R, Davidson GP, Holmes IH, Ruck BJ. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet. 1973;302:1281–1283. doi:https://doi.org/10.1016/S0140-6736(73)92867-5.
   Web of Science ®Google Scholar
• Liu K, Yang X, Wu Y, Li J. Rotavirus strategies to evade host antiviral innate immunity. Immunol Lett. 2009;127:13–18. http://www.sciencedirect.com/science/article/pii/S0165247809002120.
   PubMed Web of Science ®Google Scholar
• Clarke E, Desselberger U. Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings. Mucosal Immunol. 2015;8:1–17. doi:https://doi.org/10.1038/mi.2014.114.
   PubMed Web of Science ®Google Scholar
• Ramani S, Hu L, Venkataram Prasad BV, Estes MK. Diversity in rotavirus-host glycan interactions: A “Sweet” spectrum. Cell Mol Gastroenterol Hepatol. 2016;2:263–273. doi:https://doi.org/10.1016/j.jcmgh.2016.03.002.
   PubMed Web of Science ®Google Scholar
• Kirkwood CD. Genetic and antigenic diversity of human rotaviruses: potential impact on vaccination programs. J Infect Dis. 2010;202:S43–8. https://academic.oup.com/jid/article/202/Supplement_1/S43/848303.
   PubMed Web of Science ®Google Scholar
• Bányai K, László B, Duque J, Steele AD, Nelson EAS, Gentsch JR, Parashar UD. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine. 2012;30:Supple:A122–30. http://www.sciencedirect.com/science/article/pii/S0264410X11015532.
   PubMed Web of Science ®Google Scholar
• Todd S, Page NA, Steele AD, Peenze I, Cunliffe NA. Rotavirus strain types circulating in Africa: review of studies published during 1997–2006. J Infect Dis. 2010;202:S34–42. doi:https://doi.org/10.1086/653555.
   PubMed Web of Science ®Google Scholar
• Van Trang N, Vu HT, Le NT, Huang P, Jiang X, Anh DD. Association between norovirus and rotavirus infection and histo-blood group antigen types in vietnamese children. J Clin Microbiol. 2014;52:1366–1374. http://jcm.asm.org/content/52/5/1366.abstract.
   PubMed Web of Science ®Google Scholar
• Payne D, Currier R, Staat M, Al E. Epidemiologic association between FUT2 secretor status and severe rotavirus gastroenteritis in children in the united states. JAMA Pediatr. 2015;169:1040–1045. doi:https://doi.org/10.1001/jamapediatrics.2015.2002.
   PubMed Web of Science ®Google Scholar
• Ayouni S, Sdiri-Loulizi K, Rougemont AD, Estienney M, Ambert-Balay K, Aho S, Hamami S, Aouni M, Neji-Guediche M, Pothier P, et al. Rotavirus P[8] infections in persons with secretor and nonsecretor phenotypes, Tunisia. Emerg Infect Dis J. 2015;21:2055–2058. http://wwwnc.cdc.gov/eid/article/21/11/14-1901.
   PubMed Web of Science ®Google Scholar
• Kazi AM, Cortese MM, Yu Y, Lopman B, Morrow AL, Fleming JA, McNeal MM, Steele AD, Parashar UD, Zaidi AKM, et al. Secretor and salivary ABO blood group antigen status predict rotavirus vaccine take in infants. J Infect Dis. 2017;215:786–789. doi:https://doi.org/10.1093/infdis/jix028.
   PubMed Web of Science ®Google Scholar
• Nordgren J, Sharma S, Bucardo F, Nasir W, Günaydın G, Ouermi D, Nitiema LW, Becker-Dreps S, Simpore J, Hammarström L, et al. Both lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype–dependent manner. Clin Infect Dis. 2014;59:1567–1573. doi:https://doi.org/10.1093/cid/ciu633.
   PubMed Web of Science ®Google Scholar
• Wolf JL, Rubin DH, Finberg R, Kauffman RS, Sharpe AH, Trier JS, Fields BN. Intestinal M cells: a pathway for entry of reovirus into the host. Science. 1981;212:471–472. http://science.sciencemag.org/content/212/4493/471.abstract.
   PubMed Web of Science ®Google Scholar
• Kraehenbuhl J-P, Neutra MR. Epithelial M cells: differentiation and function. Annu Rev Cell Dev Biol. 2000;16:301–332. doi:https://doi.org/10.1146/annurev.cellbio.16.1.301.
   PubMed Web of Science ®Google Scholar
• Jung C, Hugot J-P, Barreau F. Peyer’s patches: the immune sensors of the intestine. Int J Inflam. 2010;2010:823710. http://www.hindawi.com/journals/iji/2010/823710/.
   PubMedGoogle Scholar
• Vesikari T. Rotavirus vaccination: a concise review. Clin Microbiol Infect. 2012;18:57–63. doi:https://doi.org/10.1111/j.1469-0691.2012.03981.x.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P, Van DP, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23–33. http://www.nejm.org/doi/full/10.1056/NEJMoa052664.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, Meurice F, Han HH, Damaso S, Bouckenooghe A. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007;370:1757–1763. doi:https://doi.org/10.1016/S0140-6736(07)61744-9.
   PubMed Web of Science ®Google Scholar
• Zaman K, Anh DD, Victor JC, Shin S, Yunus M, Dallas MJ, Podder G, Thiem VD, Mai LTP, Luby SP, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376:615–623. doi:https://doi.org/10.1016/S0140-6736(10)60755-6.
   PubMed Web of Science ®Google Scholar
• Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, Binka FN, Steele AD, Laserson KF, Ansah NA, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376:606–614. http://www.sciencedirect.com/science/article/pii/S0140673610608896.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362:289–298. http://www.nejm.org/doi/full/10.1056/NEJMoa0904797.
   PubMed Web of Science ®Google Scholar
• Soares-Weiser K, MacLehose H, Bergman H, Ben-Aharon I, Nagpal S, Goldberg E, Pitan F, Cunliffe N. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev. 2012;CD008521. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008521.pub3/full.
   Google Scholar
• Yih WK, Lieu TA, Kulldorff M, Martin D, McMahill-Walraven CN, Platt R, Selvam N, Selvan M, Lee GM, Nguyen M. Intussusception risk after rotavirus vaccination in U.S. Infants. N Engl J Med. 2014;370:503–512. doi:https://doi.org/10.1056/NEJMoa1303164.
   PubMed Web of Science ®Google Scholar
• Burnett E, Jonesteller CL, Tate JE, Yen C, Parashar UD. Global impact of rotavirus vaccination on childhood hospitalizations and mortality from Diarrhea. J Infect Dis. 2017;215:1666–1672. doi:https://doi.org/10.1093/infdis/jix186.
   PubMed Web of Science ®Google Scholar
• Burnett E, Yen C, Tate JE, Parashar UD. Rotavirus vaccines: current global impact and future perspectives. Future Virol. 2016;11:699–708. doi:https://doi.org/10.2217/fvl-2016-0082.
   PubMed Web of Science ®Google Scholar
• Zhen -S-S, Li Y, Wang S-M, Zhang X-J, Hao Z-Y, Chen Y, Wang D, Zhang Y-H, Zhang Z-Y, Ma J-C, et al. Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case-control design. Emerg Microbes Infect. 2015;4:e64. doi:https://doi.org/10.1038/emi.2015.64.
   PubMed Web of Science ®Google Scholar
• Anh DD, Van Trang N, Thiem VD, Anh NTH, Mao ND, Wang Y, Jiang B, Hien ND, Luan LT. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children. Vaccine. 2012;30:Supple:A114–21. http://www.sciencedirect.com/science/article/pii/S0264410X11011686.
   Web of Science ®Google Scholar
• Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, Goyal N, Kawade A, Kang G, Rathore SS, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life. Vaccine. 2014;32:Supple:A110–6. http://www.sciencedirect.com/science/article/pii/S0264410X14006185.
   Web of Science ®Google Scholar
• Isanaka S, Guindo O, Langendorf C, Matar Seck A, Plikaytis BD, Sayinzoga-Makombe N, McNeal MM, Meyer N, Adehossi E, Djibo A, et al. Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger. N Engl J Med. 2017;376:1121–1130. doi:https://doi.org/10.1056/NEJMoa1609462.
   PubMed Web of Science ®Google Scholar
• Premkumar PS, Parashar UD, Gastanaduy PA, McCracken JP, de Oliveira LH, Payne DC, Patel MM, Tate JE, Lopman BA. Reduced rotavirus vaccine effectiveness among children born during the rotavirus season: a pooled analysis of 5 case-control studies from the Americas. Clin Infect Dis. 2015;60:1075–1078. http://cid.oxfordjournals.org/content/60/7/1075.abstract.
   PubMed Web of Science ®Google Scholar
• Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, Zanardi LR, Setia S, Fair E, LeBaron CW, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564–572. doi:https://doi.org/10.1056/NEJM200102223440804.
   PubMed Web of Science ®Google Scholar
• Simonsen L, Viboud C, Elixhauser A, Taylor RJ, Kapikian AZ. More on rotashield and intussusception: the role of age at the time of vaccination. J Infect Dis. 2005;192:S36–43. doi:https://doi.org/10.1086/431512.
   PubMed Web of Science ®Google Scholar
• Armah GE, Kapikian AZ, Vesikari T, Cunliffe N, Jacobson RM, Burlington DB, Ruiz Leonard PJ. Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period. J Infect Dis. 2013;208:423–431. doi:https://doi.org/10.1093/infdis/jit174.
   PubMed Web of Science ®Google Scholar
• Parashar UD, Cortese MM, Payne DC, Lopman B, Yen C, Tate JE. Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: the example of rotavirus vaccines. Vaccine. 2015;33:D55–9. http://www.sciencedirect.com/science/article/pii/S0264410X15007781.
   PubMed Web of Science ®Google Scholar
• Atherly DE, Lewis KDC, Tate J, Parashar UD, Rheingans RD. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011–2030. Vaccine. 2012;30:Supple:A7–14. http://www.sciencedirect.com/science/article/pii/S0264410X11020457.
   Web of Science ®Google Scholar
• Babji S, Kang G. Rotavirus vaccination in developing countries. Curr Opin Virol. 2012;2:443–448. http://www.sciencedirect.com/science/article/pii/S1879625712000909.
   PubMed Web of Science ®Google Scholar
• Cherian T, Wang S, Mantel C. Rotavirus vaccines in developing countries: the potential impact, implementation challenges, and remaining questions. Vaccine. 2012;30:A3–6. http://www.sciencedirect.com/science/article/pii/S0264410X1101601X.
   PubMed Web of Science ®Google Scholar
• Rheingans R, Atherly D, Anderson J. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness. Vaccine. 2012;30:A15–23. http://www.sciencedirect.com/science/article/pii/S0264410X12000333.
   PubMed Web of Science ®Google Scholar
• Dóró R, László B, Martella V, Leshem E, Gentsch J, Parashar U, Bányai K. Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure? Infect Genet Evol. 2014;28:446–461. http://www.sciencedirect.com/science/article/pii/S1567134814003050.
   PubMed Web of Science ®Google Scholar
• Rose TL, Silva MFMD, Goméz MM, Resque HR, Ichihara MYT, Volotão EDM, Leite JPG. Evidence of vaccine-related reassortment of rotavirus, Brazil, 2008–2010. Emerg Infect Dis J. 2013;19:1843–1846. http://wwwnc.cdc.gov/eid/article/19/11/12-1407.
   PubMed Web of Science ®Google Scholar
• Bucardo F, Rippinger CM, Svensson L, Patton JT. Vaccine-derived NSP2 segment in rotaviruses from vaccinated children with gastroenteritis in Nicaragua. Infect Genet Evol. 2012;12:1282–1294. http://www.sciencedirect.com/science/article/pii/S1567134812000731.
   PubMed Web of Science ®Google Scholar
• Woodrow KA, Bennett KM, Lo DD. Mucosal vaccine design and delivery. Annu Rev Biomed Eng. 2012;14:17–46. doi:https://doi.org/10.1146/annurev-bioeng-071811-150054.
   PubMed Web of Science ®Google Scholar
• Azizi A, Kumar A, Diaz-Mitoma F, Mestecky J. Enhancing oral vaccine potency by targeting intestinal M cells. PLoS Pathog. 2010;6:e1001147. https://doi.org/10.1371/journal.ppat.1001147.
   PubMed Web of Science ®Google Scholar
• Mabbott NA, Donaldson DS, Ohno H, Williams IR, Mahajan A. Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium. Mucosal Immunol. 2013;6:666–677. doi:https://doi.org/10.1038/mi.2013.30.
   PubMed Web of Science ®Google Scholar
• Knoop KA, Kumar N, Butler BR, Sakthivel SK, Taylor RT, Nochi T, Akiba H, Yagita H, Kiyono H, Williams IR. RANKL is necessary and sufficient to initiate development of antigen-sampling M cells in the intestinal epithelium. J Immunol. 2009;183:5738–5747. http://www.jimmunol.org/content/183/9/5738.abstract.
   PubMed Web of Science ®Google Scholar
• Casteleyn C, Van Den Broeck W, Gebert A, Tambuyzer BR, Van Cruchten S, Van Ginneken C. M cell specific markers in man and domestic animals: valuable tools in vaccine development. Comp Immunol Microbiol Infect Dis. 2013;36:353–364. http://www.sciencedirect.com/science/article/pii/S0147957113000180.
   PubMed Web of Science ®Google Scholar
• Giannasca PJ, Giannasca KT, Leichtner AM, Neutra MR. Human intestinal M cells display the Sialyl Lewis A antigen. Infect Immun. 1999;67:946–953. http://iai.asm.org/content/67/2/946.abstract.
   PubMed Web of Science ®Google Scholar
• Terahara K, Yoshida M, Igarashi O, Nochi T, Pontes GS, Hase K, Ohno H, Kurokawa S, Mejima M, Takayama N, et al. Comprehensive gene expression profiling of peyer’s patch M cells, villous M-Like cells, and intestinal epithelial cells. J Immunol. 2008;180:7840–7846. http://www.jimmunol.org/content/180/12/7840.abstract.
   PubMed Web of Science ®Google Scholar
• Hase K, Kawano K, Nochi T, Pontes GS, Fukuda S, Ebisawa M, Kadokura K, Tobe T, Fujimura Y, Kawano S, et al. Uptake through glycoprotein 2 of FimH+ bacteria by M cells initiates mucosal immune response. Nature. 2009;462:226–230. doi:https://doi.org/10.1038/nature08529.
   PubMed Web of Science ®Google Scholar
• Matsumura T, Sugawara Y, Yutani M, Amatsu S, Yagita H, Kohda T, Fukuoka S-I, Nakamura Y, Fukuda S, Hase K, et al. Botulinum toxin A complex exploits intestinal M cells to enter the host and exert neurotoxicity. Nat Commun. 2015;6:7255. doi:https://doi.org/10.1038/ncomms7255.
   PubMed Web of Science ®Google Scholar
• Kim S-H, Seo K-W, Kim J, Lee K-Y, Jang Y-S. The M cell-targeting ligand promotes antigen delivery and induces antigen-specific immune responses in mucosal vaccination. J Immunol. 2010;185:5787–5795. http://www.jimmunol.org/content/185/10/5787.abstract.
   PubMed Web of Science ®Google Scholar
• Kim S-H, Jung D-I, Yang I-Y, Jang S-H, Kim J, Truong TT, Van Pham T, Truong NU, Lee K-Y, Jang Y-S. Application of an M-cell-targeting ligand for oral vaccination induces efficient systemic and mucosal immune responses against a viral antigen. Int Immunol. 2013;25:623–632. http://intimm.oxfordjournals.org/content/25/11/623.abstract.
   PubMed Web of Science ®Google Scholar
• Kim S-H, Jung D-I, Yang I-Y, Kim J, Lee K-Y, Nochi T, Kiyono H, Jang Y-S. M cells expressing the complement C5a receptor are efficient targets for mucosal vaccine delivery. Eur J Immunol. 2011;41:3219–3229. doi:https://doi.org/10.1002/eji.201141592.
   PubMed Web of Science ®Google Scholar
• Jiang T, Singh B, Li H-S, Kim Y-K, Kang S-K, Nah J-W, Choi Y-J, Cho C-S. Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan. Biomaterials. 2014;35:2365–2373. http://www.sciencedirect.com/science/article/pii/S0142961213014397.
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel). 2011;3:1377–1397. doi:https://doi.org/10.3390/polym3031377.
   PubMed Web of Science ®Google Scholar
• Singh B, Maharjan S, Jiang T, Kang S-K, Choi Y-J, Cho C-S. Attuning hydroxypropyl methylcellulose phthalate to oral delivery vehicle for effective and selective delivery of protein vaccine in ileum. Biomaterials. 2015;59:144–159. http://www.sciencedirect.com/science/article/pii/S0142961215003646.
   PubMed Web of Science ®Google Scholar
• Rouch JD, Scott A, Lei NY, Solorzano-Vargas RS, Wang J, Hanson EM, Kobayashi M, Lewis M, Stelzner MG, Dunn JCY, et al. Development of Functional Microfold (M) cells from intestinal stem cells in primary human enteroids. PLoS One. 2016;11:e0148216. doi:https://doi.org/10.1371/journal.pone.0148216.
   PubMed Web of Science ®Google Scholar
• Azegami T, Yuki Y, Kiyono H. Challenges in mucosal vaccines for the control of infectious diseases. Int Immunol. 2014;26:517–528. doi:https://doi.org/10.1093/intimm/dxu063.
   PubMed Web of Science ®Google Scholar
• Nochi T, Takagi H, Yuki Y, Yang L, Masumura T, Mejima M, Nakanishi U, Matsumura A, Uozumi A, Hiroi T, et al. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc Natl Acad Sci. 2007;104:10986–10991. http://www.pnas.org/content/104/26/10986.abstract.
   PubMed Web of Science ®Google Scholar
• Tokuhara D, Yuki Y, Nochi T, Kodama T, Mejima M, Kurokawa S, Takahashi Y, Nanno M, Nakanishi U, Takaiwa F, et al. Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine. Proc Natl Acad Sci. 2010;107:8794–8799. http://www.pnas.org/content/107/19/8794.abstract.
   PubMed Web of Science ®Google Scholar
• Ohno H. A physician-initiated translation of independent single-blind research for rice-based oral cholera vaccine, MucoRice-CTB in healthy volunteers. Japan. UMIN Clin Trials Regist identifier UMIN000009688. 2013; https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011211.
   Google Scholar
• Suh H, Shin J, Kim Y-C. Microneedle patches for vaccine delivery. Clin Exp Vaccine Res. 2014;3:42–49. http://synapse.koreamed.org/DOIx.php?id=10.7774%2Fcevr.2014.3.1.42.
   PubMedGoogle Scholar
• Arya J, Prausnitz MR. Microneedle patches for vaccination in developing countries. J Control Release. 2016;240:135–141. http://www.sciencedirect.com/science/article/pii/S016836591530242X.
   PubMed Web of Science ®Google Scholar
• Moon S, Wang Y, Edens C, Gentsch JR, Prausnitz MR, Jiang B. Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch. Vaccine. 2013;31:3396–3402. http://www.sciencedirect.com/science/article/pii/S0264410X12016209.
   PubMed Web of Science ®Google Scholar
• Wang Y, Vlasova A, Velasquez DE, Saif LJ, Kandasamy S, Kochba E, Levin Y, Jiang B. Skin vaccination against rotavirus using microneedles: proof of concept in gnotobiotic piglets. PLoS One. 2016;11:e0166038. doi:https://doi.org/10.1371/journal.pone.0166038.
   PubMed Web of Science ®Google Scholar
• Kraan H, Vrieling H, Czerkinsky C, Jiskoot W, Kersten G, Amorij J-P. Buccal and sublingual vaccine delivery. J Control Release. 2014;190:580–592. http://www.sciencedirect.com/science/article/pii/S0168365914003861.
   PubMed Web of Science ®Google Scholar
• Bermúdez-Humarán LG, Cortes-Perez NG, Lefèvre F, Guimarães V, Rabot S, Alcocer-Gonzalez JM, Gratadoux -J-J, Rodriguez-Padilla C, Tamez-Guerra RS, Corthier G, et al. A novel mucosal vaccine based on live lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-Induced tumors. J Immunol. 2005;175:7297–7302. http://www.jimmunol.org/content/175/11/7297.abstract.
   PubMed Web of Science ®Google Scholar
• Lee J-S, Poo H, Han DP, Hong S-P, Kim K, Cho MW, Kim E, Sung M-H, Kim C-J. Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on lactobacillus casei induces neutralizing antibodies in mice. J Virol. 2006;80:4079–4087. http://jvi.asm.org/content/80/8/4079.abstract.
   PubMed Web of Science ®Google Scholar
• Maassab HF, Bryant ML. The development of live attenuated cold-adapted influenza virus vaccine for humans. Rev Med Virol. 1999;9:237–244. doi:https://doi.org/10.1002/(SICI)1099-1654(199910/12)9:4%3C237::AID-RMV252%3E3.0.CO. https://doi.org88/10.1002/(SICI)1099-1654(199910/12)9:4<237::AID-RMV252>3.0.CO;2-G
   PubMed Web of Science ®Google Scholar
• Kavanagh OV, Ajami NJ, Cheng E, Ciarlet M, Guerrero RA, Zeng CQ-Y, Crawford SE, Estes MK. Rotavirus enterotoxin NSP4 has mucosal adjuvant properties. Vaccine. 2010;28:3106–3111. http://www.sciencedirect.com/science/article/pii/S0264410X10002446.
   PubMed Web of Science ®Google Scholar
• Lappalainen S, Pastor AR, Malm M, López-Guerrero V, Esquivel-Guadarrama F, Palomares LA, Vesikari T, Blazevic V. Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine. Arch Virol. 2015;160:2075–2078. doi:https://doi.org/10.1007/s00705-015-2461-8.
   PubMed Web of Science ®Google Scholar
• Szatraj K, Szczepankowska AK, Chmielewska-Jeznach M. Lactic acid bacteria — promising vaccine vectors: possibilities, limitations, doubts. J Appl Microbiol. 2017;123:325–339. doi:https://doi.org/10.1111/jam.13446.
   PubMed Web of Science ®Google Scholar
• Devriendt B, De Geest BG, Goddeeris BM, Cox E. Crossing the barrier: targeting epithelial receptors for enhanced oral vaccine delivery. J Control Release. 2012;160:431–439. http://www.sciencedirect.com/science/article/pii/S0168365912000831.
   PubMed Web of Science ®Google Scholar
• Correia BE, Ban Y-EA, Holmes MA, Xu H, Ellingson K, Kraft Z, Carrico C, Boni E, Sather DN, Zenobia C, et al. Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope. Structure. 2010;18:1116–1126. doi:https://doi.org/10.1016/j.str.2010.06.010.
   PubMed Web of Science ®Google Scholar
• Ofek G, Guenaga FJ, Schief WR, Skinner J, Baker D, Wyatt R, Kwong PD. Elicitation of structure-specific antibodies by epitope scaffolds. Proc Natl Acad Sci. 2010;107:17880–17887. http://www.pnas.org/content/107/42/17880.abstract.
   PubMed Web of Science ®Google Scholar
• Spellberg B, Ibrahim AS, Yeaman MR, Lin L, Fu Y, Avanesian V, Bayer AS, Filler SG, Lipke P, Otoo H, et al. The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium staphylococcus aureus. Infect Immun. 2008;76:4574–4580. http://iai.asm.org/content/76/10/4574.abstract.
   PubMed Web of Science ®Google Scholar
• Scarselli M, Aricò B, Brunelli B, Savino S, Di Marcello F, Palumbo E, Veggi D, Ciucchi L, Cartocci E, Bottomley MJ, et al. Rational design of a meningococcal antigen inducing broad protective immunity. Sci Transl Med. 2011;3:91ra62. http://stm.sciencemag.org/content/3/91/91ra62.abstract.
   PubMed Web of Science ®Google Scholar
• Mutsch M, Zhou W, Rhodes P, Bopp M, Chen RT, Linder T, Spyr C, Steffen R. Use of the inactivated intranasal influenza vaccine and the risk of bell’s palsy in Switzerland. N Engl J Med. 2004;350:896–903. doi:https://doi.org/10.1056/NEJMoa030595.
   PubMed Web of Science ®Google Scholar
• Newsted D, Fallahi F, Golshani A, Azizi A. Advances and challenges in mucosal adjuvant technology. Vaccine. 2015;33:2399–2405. http://www.sciencedirect.com/science/article/pii/S0264410X15004260.
   PubMed Web of Science ®Google Scholar
• Bourgeois AL, Wierzba TF, Walker RI. Status of vaccine research and development for enterotoxigenic Escherichia coli. Vaccine. 2016;34:2880–2886. http://www.sciencedirect.com/science/article/pii/S0264410X16002875.
   PubMed Web of Science ®Google Scholar
• Leach S, Lundgren A, Carlin N, Löfstrand M, Svennerholm A-M. Cross-reactivity and avidity of antibody responses induced in humans by the oral inactivated multivalent enterotoxigenicEscherichia coli (ETEC) vaccine ETVAX. Vaccine. 2017;35:3966–3973. http://www.sciencedirect.com/science/article/pii/S0264410X17307831.
   PubMed Web of Science ®Google Scholar
• Lycke N, Lebrero-Fernández C. ADP-ribosylating enterotoxins as vaccine adjuvants. Curr Opin Pharmacol. 2018;41:42–51. http://www.sciencedirect.com/science/article/pii/S1471489217302151.
   PubMed Web of Science ®Google Scholar
• Stephenson I, Zambon MC, Rudin A, Colegate A, Podda A, Bugarini R, Del Giudice G, Minutello A, Bonnington S, Holmgren J, et al. Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers. J Virol. 2006;80:4962–4970. http://jvi.asm.org/content/80/10/4962.abstract.
   PubMed Web of Science ®Google Scholar
• Lewis DJM, Huo Z, Barnett S, Kromann I, Giemza R, Galiza E, Woodrow M, Thierry-Carstensen B, Andersen P, Novicki D, et al. Transient facial nerve paralysis (Bell’s Palsy) following intranasal delivery of a genetically detoxified mutant of escherichia coli heat labile toxin. PLoS One. 2009;4:e6999. doi:https://doi.org/10.1371/journal.pone.0006999.
   PubMed Web of Science ®Google Scholar
• Lundgren A, Bourgeois L, Carlin N, Clements J, Gustafsson B, Hartford M, Holmgren J, Petzold M, Walker R, Svennerholm A-M. Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study. Vaccine. 2014;32:7077–7084. http://www.sciencedirect.com/science/article/pii/S0264410X14014595.
   PubMed Web of Science ®Google Scholar
• Staats HF, Ennis FA. IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens. J Immunol. 1999;162:6141–6147. http://www.jimmunol.org/content/162/10/6141.abstract.
   PubMed Web of Science ®Google Scholar
• Kayamuro H, Yoshioka Y, Abe Y, Arita S, Katayama K, Nomura T, Yoshikawa T, Kubota-Koketsu R, Ikuta K, Okamoto S, et al. Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus. J Virol. 2010;84:12703–12712. http://jvi.asm.org/content/84/24/12703.abstract.
   PubMed Web of Science ®Google Scholar
• Ren W, Wang K, Yin J, Chen S, Liu G, Tan B, Wu G, Bazer FW, Peng Y, Yin Y. Glutamine-induced secretion of intestinal secretory immunoglobulin A: a mechanistic perspective. Front Immunol. 2016;7:503. https://www.frontiersin.org/article/10.3389/fimmu.2016.00503.
   PubMed Web of Science ®Google Scholar
• Heine SJ, Diaz-McNair J, Andar AU, Drachenberg CB, van de Verg L, Walker R, Picking WL, Pasetti MF. Intradermal delivery of Shigella IpaB and IpaD Type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes. J Immunol. 2014;192:1630–1640. http://www.jimmunol.org/content/192/4/1630.abstract.
   PubMed Web of Science ®Google Scholar
• Frederick DR, Goggins JA, Sabbagh LM, Freytag LC, Clements JD, McLachlan JB. Adjuvant selection regulates gut migration and phenotypic diversity of antigen-specific CD4+ T cells following parenteral immunization. Mucosal Immunol. 2018;11:549–561. doi:https://doi.org/10.1038/mi.2017.70.
   PubMed Web of Science ®Google Scholar
• Pulendran B. Systems vaccinology: probing humanity’s diverse immune systems with vaccines. Proc Natl Acad Sci. 2014;111:12300–12306. http://www.pnas.org/content/111/34/12300.abstract.
   PubMed Web of Science ®Google Scholar
• Tsang JS. Utilizing population variation, vaccination, and systems biology to study human immunology. Trends Immunol. 2015;36:479–493. doi:https://doi.org/10.1016/j.it.2015.06.005.
   PubMed Web of Science ®Google Scholar
• Newport MJ, Goetghebuer T, Weiss HA, Whittle H, Siegrist C-A, Marchant A. Genetic regulation of immune responses to vaccines in early life. Genes Immun. 2004;5:122–129. doi:https://doi.org/10.1038/sj.gene.6364051.
   PubMed Web of Science ®Google Scholar
• Brodin P, Jojic V, Gao T, Bhattacharya S, Angel CJL, Furman D, Shen-Orr S, Dekker CL, Swan GE, Butte AJ, et al. Variation in the human immune system is largely driven by non-heritable influences. Cell. 2015;160:37–47. doi:https://doi.org/10.1016/j.cell.2014.12.020.
   PubMed Web of Science ®Google Scholar
• Franco LM, Bucasas KL, Wells JM, Niño D, Wang X, Zapata GE, Arden N, Renwick A, Yu P, Quarles JM, et al. Integrative genomic analysis of the human immune response to influenza vaccination. Elife. 2013;2:e00299. doi:https://doi.org/10.7554/eLife.00299.
   PubMed Web of Science ®Google Scholar
• Orrù V, Steri M, Sole G, Sidore C, Virdis F, Dei M, Lai S, Zoledziewska M, Busonero F, Mulas A, et al. Genetic variants regulating immune cell levels in health and disease. Cell. 2013;155:242–256. doi:https://doi.org/10.1016/j.cell.2013.08.041.
   PubMed Web of Science ®Google Scholar
• O’Connor D, Pollard AJ. Characterizing vaccine responses using host genomic and transcriptomic analysis. Clin Infect Dis. 2013;57:860–869. http://cid.oxfordjournals.org/content/57/6/860.abstract.
   PubMed Web of Science ®Google Scholar
• Posteraro B, Pastorino R, Di Giannantonio P, Ianuale C, Amore R, Ricciardi W, Boccia S. The link between genetic variation and variability in vaccine responses: systematic review and meta-analyses. Vaccine. 2014;32:1661–1669. http://www.sciencedirect.com/science/article/pii/S0264410X14001091.
   PubMed Web of Science ®Google Scholar
• Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, Teuwen D, Pirani A, Gernert K, Deng J, Marzolf B, et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol. 2009;10:116–125. doi:https://doi.org/10.1038/ni.1688.
   PubMed Web of Science ®Google Scholar
• Nakaya HI, Wrammert J, Lee EK, Racioppi L, Marie-Kunze S, Haining WN, Means AR, Kasturi SP, Khan N, Li G-M, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol. 2011;12:786–795. doi:https://doi.org/10.1038/ni.2067.
   PubMed Web of Science ®Google Scholar
• Tsang JS, Schwartzberg PL, Kotliarov Y, Biancotto A, Xie Z, Germain RN, Wang E, Olnes MJ, Narayanan M, Golding H, et al. Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell. 2014;157:499–513. doi:https://doi.org/10.1016/j.cell.2014.03.031.
   PubMed Web of Science ®Google Scholar
• Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol. 2014;15:195–204. doi:https://doi.org/10.1038/ni.2789.
   PubMed Web of Science ®Google Scholar
• Nakaya HI, Clutterbuck E, Kazmin D, Wang L, Cortese M, Bosinger SE, Patel NB, Zak DE, Aderem A, Dong T, et al. Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood. Proc Natl Acad Sci. 2016;113:1853–1858. http://www.pnas.org/content/113/7/1853.abstract.
   PubMed Web of Science ®Google Scholar
• Sobolev O, Binda E, O’Farrell S, Lorenc A, Pradines J, Huang Y, Duffner J, Schulz R, Cason J, Zambon M, et al. Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events. Nat Immunol. 2016;17:204–213. doi:https://doi.org/10.1038/ni.3328.
   PubMed Web of Science ®Google Scholar
• Li S, Sullivan NL, Rouphael N, Yu T, Banton S, Maddur MS, McCausland M, Chiu C, Canniff J, Dubey S, et al. Metabolic phenotypes of response to vaccination in humans. Cell. 2017;169:862–877.e17. doi:https://doi.org/10.1016/j.cell.2017.04.026.
   PubMed Web of Science ®Google Scholar
• Scheiermann C, Kunisaki Y, Frenette PS. Circadian control of the immune system. Nat Rev Immunol. 2013;13:190–198. doi:https://doi.org/10.1038/nri3386.
   PubMed Web of Science ®Google Scholar
• Curtis AM, Bellet MM, Sassone-Corsi P, O’Neill LAJ. Circadian clock proteins and immunity. Immunity. 2014;40:178–186. doi:https://doi.org/10.1016/j.immuni.2014.02.002.
   PubMed Web of Science ®Google Scholar
• Man K, Loudon A, Chawla A. Immunity around the clock. Science. 2016;354:999–1003. http://science.sciencemag.org/content/354/6315/999.abstract.
   PubMed Web of Science ®Google Scholar
• Zhang R, Lahens NF, Ballance HI, Hughes ME, Hogenesch JB. A circadian gene expression atlas in mammals: implications for biology and medicine. Proc Natl Acad Sci. 2014;111:16219–16224. http://www.pnas.org/content/111/45/16219.abstract.
   PubMed Web of Science ®Google Scholar
• Froy O, Chapnik N. Circadian oscillation of innate immunity components in mouse small intestine. Mol Immunol. 2007;44:1954–1960. http://www.sciencedirect.com/science/article/pii/S0161589006006341.
   PubMed Web of Science ®Google Scholar
• Silver AC, Arjona A, Walker WE, Fikrig E. The circadian clock controls toll-like receptor 9-mediated innate and adaptive immunity. Immunity. 2012;36:251–261. doi:https://doi.org/10.1016/j.immuni.2011.12.017.
   PubMed Web of Science ®Google Scholar
• Edgar RS, Stangherlin A, Nagy AD, Nicoll MP, Efstathiou S, O’Neill JS, Reddy AB. Cell autonomous regulation of herpes and influenza virus infection by the circadian clock. Proc Natl Acad Sci. 2016;113:10085–10090. http://www.pnas.org/content/early/2016/08/10/1601895113.abstract.
   PubMed Web of Science ®Google Scholar
• Lange T, Perras B, Fehm HL, Born J. Sleep enhances the human antibody response to hepatitis a vaccination. Psychosom Med. 2003;65:831–835. https://journals.lww.com/psychosomaticmedicine/Fulltext/2003/09000/Sleep_Enhances_the_Human_Antibody_Response_to.17.aspx.
   PubMed Web of Science ®Google Scholar
• Prather AA, Hall M, Fury JM, Ross DC, Muldoon MF, Cohen S, Marsland AL. Sleep and antibody response to hepatitis B vaccination. Sleep. 2012;35:1063–1069. doi:https://doi.org/10.5665/sleep.1990.
   PubMed Web of Science ®Google Scholar
• Karabay O, Temel A, Koker AG, Tokel M, Ceyhan M, Kocoglu E. Influence of circadian rhythm on the efficacy of the hepatitis B vaccination. Vaccine. 2008;26:1143–1144. http://www.sciencedirect.com/science/article/pii/S0264410X08000030.
   PubMed Web of Science ®Google Scholar
• Long JE, Drayson MT, Taylor AE, Toellner KM, Lord JM, Phillips AC. Morning vaccination enhances antibody response over afternoon vaccination: A cluster-randomised trial. Vaccine. 2016;34:2679–2685. http://www.sciencedirect.com/science/article/pii/S0264410X16301736.
   PubMed Web of Science ®Google Scholar
• Kurupati RK, Kossenkoff A, Kannan S, Haut LH, Doyle S, Yin X, Schmader KE, Liu Q, Showe L, Ertl HCJ. The effect of timing of influenza vaccination and sample collection on antibody titers and responses in the aged. Vaccine. 2017;35:3700–3708. http://www.sciencedirect.com/science/article/pii/S0264410X17307338.
   PubMed Web of Science ®Google Scholar
• Coulson BS. Expanding diversity of glycan receptor usage by rotaviruses. Curr Opin Virol. 2015;15:90–96. http://www.sciencedirect.com/science/article/pii/S1879625715001315.
   PubMed Web of Science ®Google Scholar